Antibody Therapeutics(IF=4.5, Oxford University Press) 🎇📷 Novel Modality | Engineering a novel light-chain single-domain antibody to enable IgG-format bispecific antibody design academic.oup.com/abt/article/... #SingleDomainAntibody #LightChainOnly #BispecificAntibody